Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Cardiovascular and Metabolic Risk

A Proposal for the Cutoff Point of Waist Circumference for the Diagnosis of Metabolic Syndrome in the Japanese Population

  1. Kazuo Hara, MD, PHD123,
  2. Yumi Matsushita, PHD13,
  3. Momoko Horikoshi, MD, PHD1,
  4. Nobuo Yoshiike, MD, PHD3,
  5. Tetsuji Yokoyama, PHD4,
  6. Heizo Tanaka, MD, PHD5 and
  7. Takashi Kadowaki, MD, PHD123
  1. 1Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
  2. 2Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Tokyo, Japan
  3. 3National Institute of Health and Nutrition, Tokyo, Japan
  4. 4National Institute of Public Health, Saitama, Japan
  5. 5Seitoku College, Tokyo, Japan
  1. Address correspondence and reprint requests to Dr. Takashi Kadowaki, University of Tokyo, Graduate School of Medicine, Department of Metabolic Diseases, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: kadowaki-3im{at}h.u-tokyo.ac.jp
Diabetes Care 2006 May; 29(5): 1123-1124. https://doi.org/10.2337/dc05-2540
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading
  • IDF, International Diabetes Federation
  • NCEP III, National Cholesterol Education Program’s Adult Treatment Panel III
  • ROC, receiver operator characteristic

Over the past 2 decades, there has been a dramatic increase in the number of subjects with the metabolic syndrome in Japan as well as in Western countries. Because subjects with the metabolic syndrome have an elevated risk of development of type 2 diabetes and cardiovascular diseases (1–3), there is an urgent need to establish strategies to prevent an epidemic of this syndrome. In particular, a practical and sensitive screening system must be established to detect the metabolic syndrome. At present, there are two internationally recognized definitions of the metabolic syndrome, namely those of the World Health Organization (4) and the National Cholesterol Education Program’s Adult Treatment Panel III (NCEP III) (5). In an attempt to establish a unified definition for the metabolic syndrome, the International Diabetes Federation (IDF) has very recently announced a new definition of the metabolic syndrome that is expected to be suitable for use in clinical practice worldwide (6). The IDF defines metabolic syndrome as the presence of central obesity plus any two of the following four factors (raised triglyceride level, reduced HDL cholesterol, raised blood pressure, and raised fasting plasma glucose). The IDF recommended that the cutoff level used for the waist circumference to define central obesity should be different among different ethnic groups (7). In fact, the new IDF definition has proposed ethnicity-specific cutoff values for waist circumference, namely, 94 and 80 cm for European men and women, respectively, and 85 and 90 cm for Japanese men and women, respectively. Nonetheless, the IDF has strongly recommended that more extensive investigations should be performed before suitable cutoff levels are established for use in clinical practice (7).

In this study, we investigated the relationship between the cutoff values used for the waist circumference to define central obesity and rates of detection of subjects having multiple risk factors of the metabolic syndrome and attempted to determine the most suitable cutoff level of waist circumference for the diagnosis of metabolic syndrome in a community-based cohort.

RESEARCH DESIGN AND METHODS

Among subjects who enrolled themselves for a routine health examination in Shibata, Niigata Prefecture, from 2000 to 2001, we invited 692 subjects ranging in age from 30 to 80 years (408 men and 284 women) to participate in this study. Well-trained interviewers recorded the histories of drug usage for hyperlipidemia, hypertension, and diabetes from all participants. The waist circumference was measured midway between the lowest rib and the iliac crest with a flexible anthropometric tape (8). The present study was approved by the ethics review committee of the University of Tokyo, and written informed consent was obtained from all of the subjects.

Definition of the state of risk-factor clustering

In this study, subjects with two or more of the following four risk factors of the criteria of the NCEP III were defined as having multiple risk factors: 1) triglycerides ≥150 mg/dl, 2) HDL cholesterol <40 mg/dl in men and <50 mg/dl in women, 3) systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg, 4) fasting plasma glucose ≥110 mg/dl (impaired fasting glucose). Subjects with a history of hyperlipidemia, hypertension, or diabetes were deemed as having the respective risk factors, regardless of the biochemical values.

Statistical analyses

The receiver operator characteristic (ROC) curve for waist circumference to predict the presence of two or more risk factors of the metabolic syndrome, as defined by the NCEP III (except for waist circumstance), was plotted using JMP for Windows, Version 4.00 (SAS Institute, Cary, NC).

RESULTS

The mean age of the study subjects was 52.3 ± 9.0 years for men and 53.5 ± 9.0 years for women. The mean waist circumference was 83.5 ± 7.8 cm in men and 74.3 ± 7.6 cm in women. The prevalence of high serum triglycerides was 30.4% in men and 9.9% in women. The prevalence of low serum HDL cholesterol was 6.6% in men and 9.2% in women. The prevalence of subjects with high blood pressure as defined by the NCEP III was 43.9% in men and 34.5% in women. The prevalence of impaired fasting glucose was 24.8% in men and 10.9% in women. The prevalence of multiple risk factors was 28.7% in men and 14.1% in women.

We plotted the ROC curve to determine the cutoff values of waist circumference in relation to the detection of multiple risk factors for the Japanese population (Fig. 1). According to the ROC curve, the cutoff level yielding the maximal sensitivity plus specificity for predicting the presence of multiple risk factors was 85 cm in men and 78 cm in women. The sensitivity and specificity using these cutoff values were 70.9 and 69.8%, respectively, in men and 60.0 and 77.1%, respectively, in women. Alternatively, given that waist circumference criteria is used for the first screening of subjects as a prerequisite for the diagnosis of metabolic syndrome, setting a cutoff level to obtain a high sensitivity of at least 80% may be justified, even if it possibly considerably decreases specificity. According to the ROC curve in this study, an optimal cutoff value for waist circumference to detect multiple risk factors was 83 cm in men and 73 cm in women, with a corresponding specificity of 54.0 and 47.1%, respectively (Fig. 1).

CONCLUSIONS

In the present study, we proposed an optimal cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population: 85 cm in men and 78 cm in women, yielding the maximal sensitivity plus specificity, or 83 cm in men and 73 cm in women, yielding at least 80% sensitivity for predicting the presence of multiple risk factors. It apparently seems that the cutoff point of waist circumference described in the present study is much shorter than that recently proposed by the IDF, especially in women. However, it should be taken into consideration that there was a difference in the method of measuring waist circumference between this study and in the criteria outlined by the IDF; we measured waist circumference at the “mid” level and the IDF measured at the umbilical level. Waist circumference at the umbilical level is thought to be several centimeters longer than that measured at the “mid” level in women, whereas values measured at the “mid” and umbilical levels tend to be very similar in men. Thus, appropriate cutoff points for waist circumference at the umbilical level would be ∼80 cm in women and ∼85 cm in men. Further studies must be performed to elucidate the most suitable method of measuring waist circumference and its most appropriate cutoff point.

Figure 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1—

The ROC curves for waist circumference to predict the presence of two or more risk factors of the metabolic syndrome, as defined by the NCEP III except for waist circumstance, in men (A) and women (B). ○, cutoff waist circumference yielding the maximal sensitivity plus specificity for predicting the presence of multiple risk factors. •, cutoff waist circumference yielding at least 80% sensitivity for predicting the presence of multiple risk factors.

Footnotes

  • K.H. and Y.M. contributed equally to this work.

    A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Received January 23, 2006.
  • DIABETES CARE

References

  1. ↵
    Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in muddle-aged men. JAMA 288 : 2709 –2716,2002
    OpenUrlCrossRefPubMedWeb of Science
  2. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen M-R, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 : 683 –689,2001
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association, National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 : 433 –438,2004
    OpenUrlFREE Full Text
  4. ↵
    World Health Organization: Definition, Diagnosis and Classification of Diabetes and its Complications: Report of a WHO consultation. Geneva, World Health Org.,1999 (WHO/NCD/NCS/99.2)
  5. ↵
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel). JAMA 285 : 2486 –2497,2001
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    International Diabetes Federation: A new worldwide definition of the metabolic syndrome [article online],2005 . Available from http://www.idf.org/home. Accessed 14 April 2005
  7. ↵
    Tan C-E, Ma S, Wai D, Chew S-K, Tai E-S: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27 : 1182 –1186,2004
    OpenUrlAbstract/FREE Full Text
  8. ↵
    World Health Organization: Measuring Obesity: Classification and Description of Anthropometric Data. Geneva, World Health Org.,1989 (Nutr UD, EUR/ICP/NUT 125)
View Abstract
PreviousNext
Back to top
Diabetes Care: 29 (5)

In this Issue

May 2006, 29(5)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Proposal for the Cutoff Point of Waist Circumference for the Diagnosis of Metabolic Syndrome in the Japanese Population
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Proposal for the Cutoff Point of Waist Circumference for the Diagnosis of Metabolic Syndrome in the Japanese Population
Kazuo Hara, Yumi Matsushita, Momoko Horikoshi, Nobuo Yoshiike, Tetsuji Yokoyama, Heizo Tanaka, Takashi Kadowaki
Diabetes Care May 2006, 29 (5) 1123-1124; DOI: 10.2337/dc05-2540

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

A Proposal for the Cutoff Point of Waist Circumference for the Diagnosis of Metabolic Syndrome in the Japanese Population
Kazuo Hara, Yumi Matsushita, Momoko Horikoshi, Nobuo Yoshiike, Tetsuji Yokoyama, Heizo Tanaka, Takashi Kadowaki
Diabetes Care May 2006, 29 (5) 1123-1124; DOI: 10.2337/dc05-2540
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis
  • Sedentary Behavior and Diabetes Risk Among Women Over the Age of 65 Years: The OPACH Study
  • Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF
Show more Cardiovascular and Metabolic Risk

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.